TANDEM DIABETES CARE INC (TNDM) Stock Analyst Ratings
USA - NASDAQ:TNDM - US8753722037 - Common Stock
14.57 USD
+0.21 (+1.46%)
ChartMill assigns a Buy % Consensus number of 72% to TNDM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.82. This target is 42.88% above the current price.
TNDM was analyzed by 29 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about TNDM.
In the previous month the buy percentage consensus was at a similar level.
TNDM was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-21 | Stifel | Reiterate | Hold |
| 2025-10-15 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-07 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-09-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-08-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-08-12 | Citigroup | Upgrade | Sell -> Neutral |
| 2025-08-11 | Lake Street | Downgrade | Buy -> Hold |
| 2025-08-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-07 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-07-09 | Citigroup | Downgrade | Neutral -> Sell |
| 2025-06-16 | Truist Securities | Initiate | Hold |
| 2025-05-22 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-05-01 | Stifel | Maintains | Buy -> Buy |
| 2025-05-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-01 | Baird | Maintains | Neutral -> Neutral |
| 2025-05-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-10 | Mizuho | Initiate | Neutral |
| 2025-03-05 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-03-04 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-03-03 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-03-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-27 | Baird | Maintains | Neutral -> Neutral |
TANDEM DIABETES CARE INC / TNDM FAQ
What is the average price target for TANDEM DIABETES CARE INC (TNDM) stock?
29 analysts have analysed TNDM and the average price target is 20.82 USD. This implies a price increase of 42.88% is expected in the next year compared to the current price of 14.57.
Can you provide the consensus rating for TANDEM DIABETES CARE INC stock?
The consensus rating for TANDEM DIABETES CARE INC (TNDM) is 71.7241 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for TANDEM DIABETES CARE INC stock?
The number of analysts covering TANDEM DIABETES CARE INC (TNDM) is 29.